VYNE Therapeutics Inc. (VYNE) Social Stream
VYNE Therapeutics Inc (VYNE) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering VYNE Therapeutics Inc.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Over the past 47 weeks, VYNE's average upside potential has been 251.07%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
VYNE Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how VYNE Therapeutics Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -296.32% of that group.
- VYNE has a greater upside potential (average analyst target price relative to current price) than 391.82% of all US stocks.
- To contextualize these metrics, consider that out of Healthcare stocks, VYNE Therapeutics Inc's average analyst price target is higher than 43.6% of them.
- VYNE has a higher number of analysts covering the stock than 317.6% of stocks in the small market cap category.
Is VYNE a Buy, Hold or Sell? See the POWR Ratings now!